Home > Journals > Minerva Cardioangiologica > Past Issues > Minerva Cardioangiologica 2014 October;62(5) > Minerva Cardioangiologica 2014 October;62(5):421-6

CURRENT ISSUE
 

ARTICLE TOOLS

Reprints

MINERVA CARDIOANGIOLOGICA

A Journal on Heart and Vascular Diseases


Official Journal of the Italian Society of Angiology and Vascular Pathology
Indexed/Abstracted in: EMBASE, PubMed/MEDLINE, Science Citation Index Expanded (SciSearch), Scopus
Impact Factor 0,695


eTOC

 

REVIEWS  


Minerva Cardioangiologica 2014 October;62(5):421-6

Copyright © 2014 EDIZIONI MINERVA MEDICA

language: English

Polymer-free amphilimus-eluting stents in patients with diabetes mellitus

Romaguera R., Gómez-Lara J., Jacobi F., Gomez-Hospital J. A., Cequier A.

Heart Diseases Institute, Hospital de Bellvitge‑IDIBELL, University of Barcelona, Barcelona, Spain


PDF  


Despite several improvements in drug-eluting stents design, diabetes mellitus (DM) remains an Achilles’ heel for percutaneous coronary revascularization at the present time. The Cre8 stent is a third-generation drug-eluting stent devoid of polymer. The drug, which is formulated with an amphiphilic carrier, is eluted from laser-dug wells on the stent’s abluminal surface. The Cre8 stent hat has shown promising preliminary results in patients with DM. This review summarizes the mechanisms of DES failure in patients with DM and the potential role of the Cre8 stent in this high-risk population.

top of page

Publication History

Cite this article as

Corresponding author e-mail

rafaromaguera@gmail.com